Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03820830
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2019-01-25
Brief Title:
Palbociclib for HR Positive HER2-negative Isolated Locoregional Recurrence of Breast Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Organization Data
Organization:
ETOP IBCSG Partners Foundation
Class:
NETWORK
Study ID:
IBCSG 59-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ETOP IBCSG Partners Foundation
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |